Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Wheaton Precious Metals Corp.

Start price
Target price
Perf. (%)
€36.08
13.12.21
-
13.12.22
4.19%
25.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€8.47
13.12.21
-
13.12.22
-67.06%
14.12.22

Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
buy
Cronos Group Inc.

Start price
Target price
Perf. (%)
€3.79
13.12.21
-
13.12.22
-19.99%
24.01.22

Could be very worthwhile Investment >20% year
buy
G6 Materials Corp.

Start price
Target price
Perf. (%)
€0.66
12.12.21
-
12.12.22
1.52%
11.01.22

Algernon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.83
12.12.21
-
12.12.22
-12.65%
30.12.21

Probably not worthwhile Investment
buy
Lithium Americas Corp.

Start price
Target price
Perf. (%)
€31.51
09.12.21
€34.00
09.12.22
-27.94%
13.10.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Very low/no dividend yield expected
buy
Wheaton Precious Metals Corp.

Start price
Target price
Perf. (%)
€34.91
06.12.21
€40.00
06.12.22
6.12%
06.12.22

Could be worthwhile Investment >10% per year
buy
Barrick Gold Corp

Start price
Target price
Perf. (%)
€16.10
06.12.21
€20.00
06.12.22
-2.34%
06.12.22

Could be worthwhile Investment >10% per year
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€5.22
05.12.21
€2.70
05.12.22
-44.67%
16.03.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€12.14
05.12.21
€18.00
05.12.22
-52.54%
06.12.22

Could be worthwhile Investment >10% per year
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.62
02.12.21
-
02.12.22
45.82%
12.12.21

Risky Investment
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€4.85
01.12.21
-
01.12.22
-53.67%
02.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.96
01.12.21
€6.00
01.12.22
-2.70%
11.12.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
buy
Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€13.43
30.11.21
-
30.11.22
-52.14%
23.06.22

Risky Investment
Increased challenges to pay loans and raise capital
Higher risks for its business
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€39.25
30.11.21
-
30.11.22
-17.83%
12.12.21

Probably not worthwhile Investment
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.22
29.11.21
-
29.11.22
-16.11%
12.12.21

Could be worthwhile Investment >10% per year
buy
Yamana Gold Inc.

Start price
Target price
Perf. (%)
€3.62
29.11.21
-
29.11.22
-4.69%
11.12.21

Could be worthwhile Investment >10% per year
buy
Wheaton Precious Metals Corp.

Start price
Target price
Perf. (%)
€37.69
29.11.21
-
29.11.22
-4.27%
11.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Pan American Silver Corp.

Start price
Target price
Perf. (%)
€22.81
29.11.21
-
29.11.22
-7.80%
11.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Barrick Gold Corp

Start price
Target price
Perf. (%)
€17.30
29.11.21
-
29.11.22
-6.94%
11.12.21

Could be worthwhile Investment >10% per year
Known brand
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.00
28.11.21
-
28.11.22
7.65%
11.12.21

Could be worthwhile Investment >10% per year
American Lithium Corp

Start price
Target price
Perf. (%)
€3.71
27.11.21
€2.00
27.11.22
-40.27%
16.03.22

EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
negative Cash Flow expected
buy
Enerplus Corp.

Start price
Target price
Perf. (%)
€9.29
26.11.21
-
26.11.22
39.94%
02.03.22

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.50
22.11.21
-
22.11.22
-2.83%
28.11.21

Risky Investment
buy
Apex Resources Inc.

Start price
Target price
Perf. (%)
€0.076
21.11.21
€0.12
-
04.03.23

Could be worthwhile Investment >10% per year